Other Events ·
Emergent BioSolutions Inc. received a $52.7 million contract modification from the U.S. Department of Health and Human…
EBSEmergent BioSolutions Inc.
Emergent BioSolutions Inc. received a $52.7 million contract modification from the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to supply ACAM2000 smallpox vaccine doses, ancillaries, and diluent replacement lots. The modification exercises the seventh option year of a 10-year contract. Emergent BioSolutions Inc. operates in the biopharmaceutical industry, providing medical countermeasures and medical products for public health emergencies.